Most veterinarians treat both adrenal- and pituitary-dependent Cushing's disease with medication. The only way to "cure" Cushing's disease is to remove the adrenal tumor if the disease is adrenal-dependent and the tumor hasn't spread, says Stohlman. However, because of the complexity and risks of the surgery, most cases are treated with medication. Surgical techniques to remove pituitary tumors in dogs are being studied, but surgery is not a widely available option.
Although Cushing's is typically a lifelong condition, the disease usually can be managed with medications. "It's important for a veterinarian to see the dog regularly and do blood tests," Stohlman says. "Monitoring blood tests and response to treatment help determine the right dose, which may need to be adjusted periodically."
Frequent blood tests and veterinary checkups are usually required in the first few months after starting treatment and then every few months after that, depending on the dog's response to treatment and tolerance to the medication.
Vetoryl (trilostane), approved by the FDA in 2008 is the only drug approved to treat both pituitary- and adrenal-dependent Cushing's in dogs. This prescription drug works by stopping the production of cortisol in the adrenal glands. Vetoryl should not be given to a dog that
- has kidney or liver disease
- takes certain medications used to treat heart disease
- is pregnant
The drug's most common side effects are poor or reduced appetite, vomiting, lack of energy, diarrhea, and weakness. Occasionally, more serious side effects, including bloody diarrhea, collapse, severe sodium/potassium imbalance, and destruction of the adrenal gland may occur, and may result in death. In 2014, with input from CVM, the manufacturer updated the information about patient monitoring and side effects on the package insert. Although not proven to be caused by Vetoryl, some additional side effects reported to CVM and now included on the package insert are adrenal insufficiency, shaking, elevated liver enzymes and elevated kidney tests.
Only one other drug, Anipryl (selegiline), is FDA-approved to treat Cushing's disease in dogs, but only to treat uncomplicated, pituitary-dependent Cushing's.
Veterinarians have often used a human chemotherapy drug, Lysodren (mitotane), "off-label" to treat Cushing's in dogs. Lysodren destroys the layers of the adrenal gland that produce cortisol. It requires careful monitoring and can have severe side effects.
"Off-label," or "extra-label," means veterinarians can legally prescribe human drugs to animals for uses not listed on the label, or for other species or at different dosage levels from those listed on the label. But because dogs may react unpredictably to human drugs, says Stohlman, it's beneficial to have treatments available that have been studied in dogs and approved specifically for them.
"Treating Cushing's is a balancing act," Stohlman says. "But dogs with the disease can live a good life if they are monitored closely by a veterinarian and the owner is diligent about bringing the dog in for blood work and checkups, watching for side effects and giving the medication as directed."